Various alkyl-(co-hydroxyalkyl) derivatives related to dibutylnitrosamine (DBN) were investigated for mutagenicity in the absence of liver-activation system. Butyl-(4-hydroxybutyl)-, butyl-(3-hydroxypropyl)-, and butyl-(2-hydroxyethyl)-nitrosamines were so tested and found to be mutagenic for TA 1535 strain of Salmonella typhimurium. In all cases, a simple dose--response relationship was observed. Furthermore, no significant (p ~ 0.05) differences in the mutagenicity of the various test compounds were observed as the alkyl sidechain possessing the OH group increased in length. From these results it is suggested that mutagenesis in S. typhimurium by the higher dialkylnitrosamines is partially due to the formation of co-hydroxylated derivatives in addition to the major mutagenic metabolite derived from a-carbon dealkylation.
Introduction
Studies on dialkylnitrosamine-induced mutagenesis in various indicator organisms have utilized DMN, a relatively well-understood mutagen and carcinogen [8, 11, 14, 22] . Recently, the need for a better understanding of nitrosamine-induced mutagenesis has shifted emphasis toward the study of a large array of nitrosamines and their metabolites [9, 12, 15, 18, 20, 21] . The
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Abbreviations: BBN, butyl-(4-hydroxybutyl)nitrosamine; BHBN-3, butyl-(3-hydroxybutyl)-nitrosamine; BHCPN, butyl-(2-hydroxy-3-carboxypropyl)nitrosamine; BHEN, butyl-(2-hydroxyethyl)-nitrosamine; BHPN, butyl-(3-hydroxypropyl)nitrosamine; BOPN, N-butyl-N-(2-oxopropyl)nitrosamine; DBN, dibutylnitrosamine; DMN, dimethylnitrosamine; HEHBN, N-(2-hydroxyethyl)-N-(4-hydroxybutyl)nitrosamine; NEE, N-nitroso-2-(ethylamino)ethanol. mutagenicity of the higher members of the homologous series such as DBN is thought to be attributable to product(s) of oxidative dealkylation at the carbon adjacent to the amine-nitrogen Druckery et al. [5, 6] . The a-hydroxylation hypothesis explains reasonably well the mutagenicity of all dialkylnitrosamines, regardless of the number of carbon atoms in the alkyl chain. The a-position is only one of a number of sites availabl~ for oxidation, other sites being ~, w, ¢~-1 [3,4, 10, 16, 19, 20] . Although these derivatives are not necessarily the "active" or "proximal" mutagens, they nevertheless represent oxidation products which may be mutagenic in the absence or presence of a metabolic activation system. BBN, BHPN, and BHEN were compared for mutagenic activity using S. typhimurium strain (TA 1535) [1] . The selection of alkyl-(co-hydroxyalkyl)-nitrosamines used in this study was based on the following considerations: BBN is a known metabolite of DBN [3, 4] and recent work by Okada and Hashimoto, [17] on the carcinogenic nature of certain alkyl-(w-hydroxyalkyl)nitrosamines shows that not all terminally-hydroxylated dialkylnitrosamines are carcinogenic. Studies [2, 7] demonstrating the carcinogenic nature of alkyl-(co-hydroxyalkyl)nitrosamines has led to the assumption that all ¢o-hydroxylated nitrosamines are carcinogenic. However, Okada and Hashimoto [17] have shown that BHPN is non-carcinogenic to rats whereas the other ¢o-hydroxylated nitrosamines studied were carcinogenic. It was felt therefore that in vitro microbial mutagenesis studies would help resolve the findings regarding the biological effects of vg-hydroxylated nitrosamines, since many compounds that are carcinogenic have also been shown to be mutagenic.
Materials and methods

Synthesis of ¢o-hydroxylated N-nitroso compounds
The alkyl-(w-hydroxyalkyl)nitrosamines (BBN, BHPN and BHEN) were synthesized from commercially available starting materials according to the procedure of Druckery et al. [6] . Nitrosation of the secondary amine resulted in a mixture of alcohol [alkyl-(w-hydroxyalkyl)nitrosamine] and nitrite ester. Extensive acid hydrolysis was required to convert the nitrite ester to the alcohol. Distillation in vacuo produced a pale, yellow, viscous oil: BBN, b.p. 127--129°C/0.09 mm Hg (Lit. 116°C/0.01 mm Hg); BHPN, b.p. 123--127°C/ 0.9 mm Hg (Lit. 144°C/3.0 mm Hg); and BHEN, b.p. 115--117°C/1.5 mm Hg (Lit. 148°C/7.0 mm Hg). Identity and purity of the alkyl-(c~-hydroxyalkyl)-nitrosamines were confirmed by IR spectroscopy, GC-mass spectroscopy, and thin-layer chromatography.
Mu tagenesis assay
The histidine auxotroph (his-) of S. typhimurium (strain TA 1535) was obtained from Dr. Bruce Ames (Biochemistry Department, University of California Berkeley, Calif.). Starter cultures of S. typhimurium were initiated by inoculating nutrient broth (Difco) from stock stab-cultures. When the subcultured S. typhimurium had increased in density to a Mac Farland No. 2 standard (1 X 108 cells/ml), the cell culture was centrifuged at 1500 rpm for 15 min and resuspended in sterile 0.85% saline. Plates were prepared according to the pro- Control values were subtracted from the number treated bacteria.
Results are expressed as mean ± S.E.
of colonies counted for ¢o-hydroxylated nitrosamine-
Discussion
In the absence of liver microsomes, BBN, BHPN and BHEN were found to be mutagenic for S. typhimurium (TA 1535). These studies suggest that oxidation products of the higher dialkylnitrosamines are mutagenic in the absence of a metabolic activation system. In contrast to our findings, Okada et al. [18] and Nagao et al. [13] have shown BBN to be non-mutagenic for S. typhimurium strain (TA 1535) in the, absence of liver extract. Hsieh et al. [9] have examined NEE, a w-hydroxylated nitrosamine, for mutagenic activity and found this compound to be non-mutagenic for S. typhimurium (TA 1535). In the study by Nagao and co-workers [13] , mutagenesis studies of selected hydroxy and oxo derivatives of DBN showed the following compounds to be mutagenic in the absence of liver homogenate: BHBN-3, BHCPN, and BOPN. Furthermore, various di-(~-hydroxyalkyl)nitrosamines, namely, HEHBN and related compounds were definitely but weakly mutagenic in the absence of an activation system.
To explain the apparent discrepancy between our results with mono-(~-hydroxyalkyl)nitrosamines and those of Okada et al. [18] and Nagao et al. [13] , we have focused on the quantity and availability of mutagen to the bacteria. In our procedure, the possibility of a non-specific interaction between the test compounds and the growth media was eliminated by the utilization of resuspended bacteria in 0.85% saline. The findings of Nagao et al. [13] concerning the mutagenicity of various hydroxylated derivatives would seem to indicate that any or all hydroxylated derivatives of a higher dialkylnitrosamine, e.g. DBN, are potentially mutagenic in the absence of a metabolic activation system. Furthermore, it is evident that there is an absolute requirement of the microsomal fraction for the conversion of parent compound to the hydroxylated moiety, a metabolic conversion capability which is apparently lacking in bacteria. However, bacteria (as shown by our data and by Nagao [13] ) can convert the hydroxylated derivatives to mutagenic products. The mutagenicity of the various hydroxylated nitrosamines reflects a combined mutagenic effect from the product(s) derived from ~fl,co,co-1 hydroxylation. Additional work is needed to determine those oxidation products of higher dialkylnitrosamines which are mutagenic per se or require further metabolism to exert their mutagenic effect.
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